Ascendis Pharma A/S (A1SN34 SA) stock market data APIs
R$75.1728
0(0%)
as of December 23, 2025
Try our APIs with
free plan!
Ascendis Pharma A/S Financial Data Overview
Price chart is built with
Anychart
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Prev. Close
75.1728
Open
75.1728
High
75.1728
Low
75.1728
52 wk Range
53.79-77
Market Cap
69 376 M
Shares Outstanding
61 098 K
Revenue
647 M
Beta
0.443
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ascendis Pharma A/S data using free add-ons & libraries
Get Ascendis Pharma A/S Fundamental Data
Ascendis Pharma A/S Fundamental data includes:
- Net Revenue: 647 M
- EBITDA: -133 708 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ascendis Pharma A/S News
New
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European equities traded in the US as American depositary receipts were trending higher late Wednesd PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European equities traded in the US as American depositary receipts started the week higher late Mond PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Assessing Ascendis Pharma’s 2025 Valuation After Big Run and DCF Upside Potential
If you are wondering whether Ascendis Pharma is still a smart buy after its big run, or if the market has already priced in the upside, this overview is designed to give you a clear, valuation-focused...
European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading
European equities traded in the US as American depositary receipts were tracking higher late Thursda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
